Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

[New aspects on the pathogenesis of myositis].

Stuhlmüller B, Feist E, Häupl T, Burmester GR, Pipitone N.

Z Rheumatol. 2013 Apr;72(3):209-19. doi: 10.1007/s00393-012-1078-5. German.

PMID:
23515563
2.

Possible pathogenic mechanisms in inflammatory myopathies.

Lundberg IE, Dastmalchi M.

Rheum Dis Clin North Am. 2002 Nov;28(4):799-822. Review.

PMID:
12506773
3.

Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients.

Troyanov Y, Targoff IN, Tremblay JL, Goulet JR, Raymond Y, Senécal JL.

Medicine (Baltimore). 2005 Jul;84(4):231-49.

4.

[Inflammatory muscle diseases: dermatomyositis, polymyositis, and inclusion body myositis].

Genth E.

Internist (Berl). 2005 Nov;46(11):1218-32. Review. German.

PMID:
16200404
5.

Idiopathic inflammatory myopathies: from immunopathogenesis to new therapeutic targets.

Haq SA, Tournadre A.

Int J Rheum Dis. 2015 Nov;18(8):818-25. doi: 10.1111/1756-185X.12736. Review.

PMID:
26385431
7.

A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups.

Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, Miller FW.

Medicine (Baltimore). 1991 Nov;70(6):360-74.

PMID:
1659647
8.

Dendritic cells and the immunopathogenesis of idiopathic inflammatory myopathies.

de Padilla CM, Reed AM.

Curr Opin Rheumatol. 2008 Nov;20(6):669-74. doi: 10.1097/BOR.0b013e3283157538. Review.

PMID:
18946326
9.

Inflammatory myopathies.

Kingston WJ, Moxley RT 3rd.

Neurol Clin. 1988 Aug;6(3):545-61. Review.

PMID:
3065600
10.
11.

Inflammatory myopathies: evaluation and management.

Greenberg SA.

Semin Neurol. 2008 Apr;28(2):241-9. doi: 10.1055/s-2008-1062267. Review.

PMID:
18351525
12.

Inflammatory myopathies: Part 1.

Mastaglia FL, Ojeda VJ.

Ann Neurol. 1985 Mar;17(3):215-27.

PMID:
2986525
13.

[Myositis-specific autoantibodies].

Gran JT, Molberg Ø, Dobloug GC, Andersson H, Taraldsrud E, Scheie D.

Tidsskr Nor Laegeforen. 2009 Aug 27;129(16):1631-4. doi: 10.4045/tidsskr.09.35501. Review. Norwegian.

14.

[Comprehensive understanding and study on idiopathic inflammatory myopathies to improve its diagnosis and treatment].

Xie QB, Liu G.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2013 Sep;44(5):792-6. Chinese.

PMID:
24325114
15.

A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies.

Dastmalchi M, Grundtman C, Alexanderson H, Mavragani CP, Einarsdottir H, Helmers SB, Elvin K, Crow MK, Nennesmo I, Lundberg IE.

Ann Rheum Dis. 2008 Dec;67(12):1670-7. doi: 10.1136/ard.2007.077974.

PMID:
18272672
17.

Role of cytokines and chemokines in idiopathic inflammatory myopathies.

De Paepe B, Creus KK, De Bleecker JL.

Curr Opin Rheumatol. 2009 Nov;21(6):610-6. doi: 10.1097/BOR.0b013e3283317b31. Review.

PMID:
19726994
18.

NIH conference. Myositis: immunologic contributions to understanding cause, pathogenesis, and therapy.

Plotz PH, Rider LG, Targoff IN, Raben N, O'Hanlon TP, Miller FW.

Ann Intern Med. 1995 May 1;122(9):715-24. Review.

PMID:
7702234
19.

Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies.

Hengstman GJ, Brouwer R, Egberts WT, Seelig HP, Jongen PJ, van Venrooij WJ, van Engelen BG.

J Neurol. 2002 Jan;249(1):69-75.

PMID:
11954871
20.

[Therapeutic strategies in idiopatic inflammatory myopathies].

Chakour R, Leimgruber A, Bart PA, Spertini F.

Rev Med Suisse. 2009 Apr 15;5(199):812-8. French.

PMID:
19441746

Supplemental Content

Support Center